JAGX — Jaguar Health Cashflow Statement
0.000.00%
Last trade - 00:00
- $43.34m
- $72.67m
- $9.76m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -38.5 | -33.8 | -52.6 | -49.1 | -41.9 |
Depreciation | |||||
Non-Cash Items | 17 | 20.3 | 13.6 | 18.4 | 17.7 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.662 | -3.47 | 2.27 | -4.43 | -11.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -20.5 | -15.3 | -35 | -33.1 | -33.2 |
Capital Expenditures | — | -0.007 | -0.006 | -1.68 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | 0 | -0.007 | -0.006 | -1.68 | 0 |
Financing Cash Flow Items | -2.57 | -1.01 | -0.731 | -1.16 | 0.38 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 21.8 | 19.5 | 43.9 | 23.2 | 34.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.32 | 4.21 | 8.96 | -11.6 | 1 |